ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025

STX-721, a Covalent EGFR/HER2 Exon 20 Inhibitor, Utilizes Exon 20-Mutant Dynamic Protein States and Achieves Unique Mutant Selectivity Across Human Cancer Models.

Raymond A Pagliarini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.